Merck touts new data for Keytruda combos in NSCLC at North American conference
Merck marched out new data from two studies on Friday to back king Keytruda — the drug that made the Big …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
